Veritas Pharma Stock Analysis
| VRTHF Stock | USD 0 0.00 0.00% |
Veritas Pharma is overvalued with Real Value of 0.00126 and Hype Value of 0.0015. The main objective of Veritas Pharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Veritas Pharma is worth, separate from its market price. There are two main types of Veritas Pharma's stock analysis: fundamental analysis and technical analysis.
The Veritas Pharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Veritas Pharma's ongoing operational relationships across important fundamental and technical indicators.
Veritas |
Veritas Pink Sheet Analysis Notes
About 27.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.43. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Veritas Pharma recorded a loss per share of 0.03. The entity last dividend was issued on the 11th of February 2019. The firm had 1:2 split on the 10th of December 2021. Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States.The quote for Veritas Pharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Lorne Roseborough at 416-918-6785 or visit http://www.veritaspharmainc.com.Veritas Pharma Investment Alerts
| Veritas Pharma generated a negative expected return over the last 90 days | |
| Veritas Pharma has some characteristics of a very speculative penny stock | |
| Veritas Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Veritas Pharma has accumulated 765.63 K in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Veritas Pharma has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Veritas Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Veritas Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Veritas Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Veritas to invest in growth at high rates of return. When we think about Veritas Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.29 M) with loss before overhead, payroll, taxes, and interest of (112.96 K). | |
| Veritas Pharma has accumulated about 125.27 K in cash with (294.86 K) of positive cash flow from operations. | |
| Roughly 27.0% of Veritas Pharma outstanding shares are owned by insiders |
Veritas Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Veritas Pharma's market, we take the total number of its shares issued and multiply it by Veritas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Veritas Pharma, as well as the relationship between them.Veritas Pharma Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Veritas Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Veritas Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Veritas Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Veritas Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Veritas shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Veritas Pharma. By using and applying Veritas Pink Sheet analysis, traders can create a robust methodology for identifying Veritas entry and exit points for their positions.
Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Veritas Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Complementary Tools for Veritas Pink Sheet analysis
When running Veritas Pharma's price analysis, check to measure Veritas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veritas Pharma is operating at the current time. Most of Veritas Pharma's value examination focuses on studying past and present price action to predict the probability of Veritas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veritas Pharma's price. Additionally, you may evaluate how the addition of Veritas Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |